Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03922542
PHASE2/PHASE3
Comparison of Standard vs. Accelerated Corneal Crosslinking
Sponsor: Price Vision Group
View on ClinicalTrials.gov
Summary
The study objective is to compare accelerated and standard corneal crosslinking for treatment of progressive keratoconus or corneal ectasia.
Official title: Randomized Comparison of Standard vs. Accelerated Corneal Crosslinking for Treatment of Progressive Keratoconus or Ectasia
Key Details
Gender
All
Age Range
10 Years - Any
Study Type
INTERVENTIONAL
Enrollment
510
Start Date
2019-04-16
Completion Date
2026-07-01
Last Updated
2025-07-31
Healthy Volunteers
No
Conditions
Interventions
COMBINATION_PRODUCT
riboflavin 0.1%
Use of riboflavin 0.1% eye drops and 9 mW/cm2 UVA light for 10 minutes
COMBINATION_PRODUCT
Riboflavin 0.1%
Use of riboflavin 0.1% eye drops and 3 mW/cm2 UVA light for 30 minutes
Locations (1)
Price Vision Group
Indianapolis, Indiana, United States